Word

IMPERA MEDICINES

Status

Pending

Status Code

630

Status Date

Wednesday, March 20, 2024

Serial Number

98459161

Mark Type

4000

Filing Date

Wednesday, March 20, 2024

Trademark Owner History

Impera Medicines, LP

Classifications

5 medicinal preparations for the treatment of infectious diseases and for use in oncology; biological preparations for the treatment of cancer; anti-cancer preparations; medicinal preparations for the treatment of cardiometabolic diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of cardiometabolic diseases; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, cardiometabolic, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

36 investment consultancy for biotechnology companies; investment management for biotechnology companies; financial services, namely, investment management and advisory services in the field of biotechnology; intellectual property venture fund management services in the field of biotechnology

35 usiness consultancy in the field of biotechnology; professional business consulting for biotechnology companies; business consulting, business management and providing information in the biotechnology business field; business services, namely, assisting the owners of intellectual property and intangible assets in the field of biotechnology in finding investors

42 research and development services in the fields of immunology and oncology; research and development services in the field of cardiometabolic diseases; medical research in the field of oncology; medical research in the field of immunology; medical research in the field of cardiometabolic diseases; research, development, engineering and testing services in the field of pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, cardiometabolic, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events

Mar 20, 2024

New Application Entered